NCT00382161View on ClinicalTrials.gov

Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors

PHASE3WithdrawnINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

December 31, 2007

Conditions
Impotence
Interventions
DRUG

Fluvastatin-sodium

Trial Locations (1)

66421

University Hospital of the Saarland, Homburg

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Hospital, Saarland

OTHER

NCT00382161 - Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors | Biotech Hunter | Biotech Hunter